Header Logo

Connection

Rafal Gulej to Cell Line, Tumor

Back to Details
This is a "connection" page, showing publications Rafal Gulej has written about Cell Line, Tumor.
Rafal Gulej
Connection Strength
0.032
Cell Line, Tumor
  1. Optimized monoclonal antibody treatment against ELTD1 for GBM in a G55 xenograft mouse model. J Cell Mol Med. 2020 01; 24(2):1738-1749.
    View in: PubMed
    Score: 0.032
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.